FAST NEWS: Zai Lab’s Loss Widens as R&D Costs Surge
The latest: Biotech company Zai Lab Ltd. (9688.HK; ZLAB.US) on Thursday reported a $161 million net loss in the third quarter, 67% wider than its $96.41 million loss a year…
3D Medicines Bleeds Red Ink As It Struggles to Swim in ‘Red Ocean’
The loss-making innovative oncology drug company with just one approved product on the market is making a third tilt for a listing on the Hong Kong Stock Exchange Key Takeaways:…
RELATED ARTICLES
-
FAST NEWS: Zai Lab’s loss narrows on strengthening sales
9688.HK ZLAB.US -
FAST NEWS: Zai Lab’s loss narrows on growing revenue
ZLAB.US 9688.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Everest reaches new heights on growing drug sales
1952.HK
-
With no cure in sight, drugs firm LianBio begins exit strategy
LIAN.US
